Health Sector Current Affairs

NITI Aayog’s SATH Program launched in Assam

National Institution for Transforming India (NITI) Aayog’s SATH (Sustainable Action for Transforming Human capital) Program was launched in in Guwahati, Assam.

The SATH program aims to provide structured support to Assam in identifying key health priorities and implement the solutions towards transforming the health and improving the well-being of people of state.

SATH program

The vision of SATH program is to initiate transformation in education and health sectors. It embodies the philosophy of co-operative federalism to addresses the need expressed by many states for technical support from NITI Aayog. The program will be implemented by NITI along with McKinsey & Company and IPE Global consortium, who were selected through a competitive bidding process.

SATH Program aims to build three selected states viz. Assam, Uttar Pradesh and Karnataka as future ‘role model’ states for health systems. Under it, NITI Aayog will work in close collaboration with state machinery in these three selected states to design a robust roadmap of intervention, develop program governance structure, set up monitoring and tracking mechanisms, handhold state institutions through the execution stage and provide support on a range of institutional measures to achieve the end objectives.

Tags:

IIT Researchers develops bioartificial implantable pancreas

Researchers from Indian Institute of Technology (IIT) Guwahati have successfully created an implantable bioartificial pancreas model grown within 3D silk scaffold.

The bioartificial pancreas encapsulates insulin-producing beta cells, capable of naturally producing insulin in sustained manner. If successful in animal and human trials, it can be used for treating people with Type 1 diabetes. Type 1 diabetes arises when the body’s immune system kills the insulin-producing beta cells.

Key Facts

The 3D silk scaffold was found to be biocompatible (not toxic to living tissue) as it did not trigger any immune reaction or cause any adverse reaction after implanted. It was made porous by using salt grains of specific size to dissolve the silk proteins. These pores were 400-500 micrometre in size which allowed glucose and oxygen to enter scaffold and insulin released by beta cells with greater survival rate to enter bloodstream.

The scaffold containing beta cells was coated with a semi-permeable membrane barrier. The membrane allowed insulin produced to be released into blood stream and does not allow immune cells to cross membrane and kill the islet cells.

To ensure that the implant is not rejected by the body’s immune system, drugs that suppress the immune system were embedded in the scaffold. Studies carried in lab showed that beta cells in scaffold were able to produce adequate amount of insulin in response to different glucose levels within a few seconds.

Tags:

12345...7